Can antiglycolipid antibodies present in HIV-infected individuals induce immune demyelination?

Neuropathology

Volumn 20, Issue 4, 2000, Pages 257-272

  Petratos, Steven ^a   Gonzales, Michael F ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Antibodies; Galactocerebroside; Gangliosides; Human immunodeficiency virus; Inflammatory demyelinating polyneuropathy; Sulfatide

Indexed keywords

ANTIBODY; ANTIGLYCOLIPID ANTIBODY; CARBOHYDRATE; GALACTOSYLCERAMIDE; GANGLIOSIDE; GLYCOLIPID; GLYCOPROTEIN; MYELIN; NERVE PROTEIN; PROTEIN P2; SULFATIDE; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; DEMYELINATING DISEASE; DEMYELINATION; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATORY DEMYELINATING POLYNEUROPATHY; NEUROPATHY; PERIPHERAL NERVE; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR CORTEX;

ANIMALS; GANGLIOSIDES; GLYCOLIPIDS; HIV INFECTIONS; HUMANS; MYELIN SHEATH; POLYNEUROPATHIES; POLYRADICULONEUROPATHY; SULFOGLYCOSPHINGOLIPIDS;

EID: 0034494183     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1789.2000.00356.x     Document Type: Review

References (170)

1. Neurological complications of acquired immune deficiency syndrome, analysis of 50 patients
2. Neurological manifestations of the acquired immune deficiency syndrome (AIDS), experience at UCSF and review of the literature
3. Peripheral neuropathy associated with acquired immunodeficiency syndrome
4. Infraclinical neuropathies related to immunodeficiency virus infection associated with higher T-helper cell count
5. Identification of mononuclear cells in CSF of patients with HIV infection
6. Neuromuscular complications of HIV infection and its treatment
7. Isolation of LAV/HTLV-III from a patient with amyotropic lateral sclerosis
8. Damage to jejunal intrinsic autonomic nerves in HIV infection
9. Peripheral facial paralysis and HIV infection: Report of four African cases and review of the literature
10. Fisher's syndrome associated with human immunodeficiency virus infection
11. Subacute AIDS-related lumbosacral radiculopathy: A bacterial infection?
12. Abnormalities of peripheral nerve in patients with human immunodeficiency virus infection
13. The pathology of the posterior root ganglia in AIDS and its relationship to the pallor of the gracile tract
14. Antibody-mediated peripheral neuropathies associated with ARC and AIDS. Successful treatment with plasmapheresis
15. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotrophic virus type III infection
16. Neuromuscular diseases associated with human immunodeficiency virus infection
17. Assessment of current diagnostic criteria for Guillain-Barré syndrome
18. Peripheral neuropathies associated with human immunodeficiency virus infection
19. Human immunodeficiency virus (HIV)-related chronic relapsing inflammatory demyelinating polyneuropathy with multifocal unusual onion bulbs in sural nerve biopsy
20. Non-neural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy
21. Activated T cells of nonneuronal specificity open the blood-nerve barrier to circulating antibody
22. Polyneuropathy in the acquired immune deficiency syndrome
23. The use of plasmapheresis, lymphocytapheresis, and staph protein-A immunoadsorption as an immunomodulatory therapy in patients with AIDS and AIDS-related conditions
24. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies
25. Chronic inflammatory demyelinating polyneuropathy as first manifestation of human immunodeficiency virus infection
26. Incorporation of P0 protein into liposomes: Demonstration of a two-domain structure by immunochemical and PAGE analysis
27. Occurrence and isotype of antibodies against peripheral nerve myelin in serum from patients with peripheral neuropathy and healthy controls
28. Anti-peripheral myelin antibodies in Guillain-Barré syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen
29. Neuropathy and myopathy in primary Sjogren's syndrome: Neurophysiological, immunological and muscle biopsy results
30. Quantitative analysis of monoclonal immunoglobulins in serum of patients with amyotrophic lateral sclerosis
31. In vitro synthesis of antibodies to myelin antigens by Epstein-Barr virus-transformed B lymphocytes from patients with neurologic disorders
32. Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinating neuropathy
33. Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons
34. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: Further evidence that IgM-MGUS neuropathies are different than IgG-MGUS
35. Cloning of human anti-GM1 antibodies from motor neuropathy patients
36. High titre IgM anti-sulphatide antibodies in patients with IgM paraproteinaemia and inflammatory demyelinating polyneuropathy
37. Prednisone improves chronic inflammatory demyelinating polyradiculneuropathy
38. Plasma exchange in chronic inflammatory demyelinating polyradiculopathy
39. Plasma exchange in Guillain-Barré syndrome: Effect on anti-peripheral nerve myelin antibodies
40. Reactivity of human monoclonal IgM with nerve glycosphingolipids
41. 1 and sulphatide of peripheral nerve myelin
42. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome
43. Anti-sulphatide antibodies in peripheral neuropathy
44. 1 antibodies
45. Immunoregulation in man
46. Human B lymphocytes: Phenotype, proliferation, and differentiation
47. T cell responses to myelin proteins in Guillain-Barré syndrome
48. MHC interaction and T cell recognition of carbohydrates and glycopeptides
49. Induction of IgG3 secretion by interferon γ: A model for T cell-independent class switching in response to T cell-independent type 2 antigens
50. Neuropathy and anti-GM1 antibodies
51. Selection of autoantibody specificities in the Lyl-1 B subset
52. CD5 B cells, a fetal B cell lineage
53. - T lymphocytes to a microbial antigen
54. The CD1 System: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
55. The distribution of CD1 molecules in inflammatory neuropathy
56. Self glycolipids as T-cell antigens
57. Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy
58. Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein
59. Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis
60. IgM in human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside
61. Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy
62. Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy
63. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein
64. Demyelination induced by intraneural injection of human anti-myelin-asociated glycoprotein antibodies
65. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein
66. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein
67. Anti-sulfatide antibodies in neurological disease, binding to rat dorsal root ganglia neurons
68. Immunochemical studies of lipids: Reactions of anti-sulfatide antibodies with sulfatide in liposomal and myelin membranes
69. Complete amino acid sequences of variable regions of two human IgM rheumatoid factors, BOR and KAS of the Wa idiotypic family, reveal restricted use of heavy and light chain variable and joining region gene segments
70. Structural characterization of human monoclonal cold agglutinins: Evidence for a distinct primary sequence-defined Vh4 idiotype
71. Ig H and L chain contribution to autoimmune specificities
72. DNA sequence analysis and comparison of the variable heavy and light chain regions of two IgM monoclonal anti-MAG antibodies
73. The B-cells that express anti-MAG antibodies in neuropathy and non-malignant monoclonal gammopathy belong to the CD5 subpopulation
74. Immunoelectron microscopical labelling of a glycolipid in the envelopes of brain cell derived budding viruses, Semliki Forest, influenza and measles, using a monoclonal antibody directed chiefly against galactocerebroside made by SFV immunization
75. Microenvironment of the peripheral nervous system under normal and pathological conditions
76. 4) β1-1Cer) and has a sequence homology with other proteins that bind sulfated glycoconjugates
77. Competitive binding of dynorphin-(1-13) and β-endorphin to cerebroside sulfate in solution
78. Localization of galactosylceramide and sulfatide at the surface of the myelin sheath: An immunofluorescence study in liquid medium
79. Systemic passive transfer studies using IgM monoclonal antibodies to sulfatide
80. Intrathecal synthesis of anti-sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndrome
81. High levels in serum, but no signs of intrathecal synthesis of anti-sulfatide antibodies in HIV-1 infected individuals with or without central nervous system complications
82. Antibodies against peripheral myelin glycolipids in people with HIV infection
83. High titre anti-sulphatide antibodies in HIV infected individuals
84. Peripheral nerve binding patterns of high titre anti-sulphatide antibodies present in plasma samples from HIV-infected individuals
85. Antigen-specific and polyclonal B-cell responses in patients with AIDS
86. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome
87. Clinical implications of autoantibodies in HIV infection
88. Experimental polyneuropathy produced in guinea-pigs immunized against sulfatide
89. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside
90. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis
91. Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia
92. Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome
93. Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system
94. 1 ganglioside antibodies in neuromuscular diseases, a study of 180 sera
95. T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro
96. 1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome, clinical and immunohistochemical studies
97. 1b ganglioside
98. 1b antibody in Fisher's syndrome
99. Serum antibodies to gangliosides in Guillain-Barré syndrome
100. Antibody detection in Guillain-Barré syndrome
101. Induction of antibody to asialo-GM1 by spermatozoa and its occurrence in the sera of homosexual men with the acquired immune deficiency syndrome
102. Cerebrospinal fluid antiganglioside antibodies in patients with AIDS
103. Prevalence of peripheral neuropathy in HIV disease: Prospective study of 40 patients
104. Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome
105. Peripheral neuropathy in a cohort of human immunodeficiency virus-infected patients. Incidence and relationship to other nervous system dysfunction
106. A study of neuropathy in HIV infection
107. In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum, a morphological study
108. Synthesis of cerebroside by brain from uridine diphosphate galactose and ceramide containing hydroxy fatty acid
109. The biosynthesis by brain microsomes of cerebrosides containing nonhydroxy fatty acids
110. Enzymatic synthesis of galactocerebroside by a galactosyltransferase from embryonic chick brain
111. Immune responses to myelin antigens in Guillain-Barré syndrome
112. Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disorders
113. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome
114. Myelination in rat brain. Method of myelin isolation
115. Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter disease
116. Inflammatory demyelinating polyradiculitis in a patient with acute disseminated encephalomyelitis (ADEM)
117. Acute, severe, central and peripheral nervous system combined demyelination
118. Acute severe combined demyelination
119. "Onion bulb" formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy
120. Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy
121. Hypertrophic neuropathy and multiple sclerosis
122. Combined central and peripheral myelinopathy
123. Peripheral nervous system involvement in multiple sclerosis
124. Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection
125. Autoimmunity against blood cells in human immunodeficiency virus infection
126. The human immunodeficiency virus infectivity and mechanisms of pathogenesis
127. Neuroimmunology of human immunodeficiency virus infection
128. Inflammatory neuropathy in homosexual men with lymphadenopathy
129. Molecular pathogenesis of neurotropic viral infections
130. Peripheral neuropathy in the acquired immunodeficiency syndrome
131. Interactions between CD4+ T-cells and rat Schwann cells in vitro. 1. Antigen presentation by Lewis rat Schwann cells to P2-specific CD4+ T-cell lines
132. Detection of visna virus antigens and RNA in glial cells in foci of demyelination
133. The pathogenesis of Aleutian disease of mink. 3. Immune complex arteritis
134. Can viral envelope glycolipids produce autoimmunity, with reference to the CNS and multiple sclerosis?
135. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide
136. Gangliosides: Differentiation markers for murine T helper lymphocyte subpopulations TH1 and TH2
137. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages
138. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells
139. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor
140. Virological aspects of neurological disease
141. The erythrocyte as virus carrier in Friend and Rauscher virus leukemias
142. "Forbidden clones" and auto-immunity
143. Induction of antimyelin and antioligodendrocyte antibodies by vaccinia virus. An experimental study in the mouse
144. Antilymphocyte serum and tissue culture used to investigate role of cell-mediated response in viral encephalitis in mice
145. Glycosphyngolipids of plasma membrane of cultured cells and an enveloped virus (SV5) grown in these cells
146. Studies of the hemolysis of red blood cells by mumps virus. IV. Quantitative study of changes in red blood lipids and of virus lipids
147. Lipids of influenza virus and their relation to those of the host cell
148. The lipids of incomplete influenza virus
149. Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses
150. The glycolipids and phospholipids of Sindbis virus and their relation to the lipids of the host cell plasma membrane
151. Phospholipid composition of Venezuelan equine encephalitis virus
152. The lipid class composition of Semliki Forest virus and of plasma membranes of the host cells
153. Fatty chains of different lipid classes of Semliki Forest virus and host cell membranes
154. Phospholipids of Semliki Forest virus grown in cultured mosquito cells
155. Semliki Forest virus infections in mice as a model for studying acute and chronic central nervous system virus infections in mice
156. Immunological relationship between a demyelinating RNA enveloped budding virus (Semliki Forest) and brain glycolipids
157. CNS pathogenesis following a dual virus infection with Semliki Forest (Alphavirus) and Langat (Flavivirus)
158. Immunocytochemical evidence for Semliki Forest virus antigen persistence in mouse brain
159. Antibodies against sulfatide in sera from patients with autoimmune rheumatic diseases
160. Antibodies against glycosphingolipids in sera of patients with idiopathic thrombocytopenic purpura
161. Regional distribution of sulfatide in human kidney, and anti-sulfatide antibodies in sera from patients with nephritis detected by TLC immunostaining
162. The role of sulfatides in autoimmunity in children with various glomerular disease
163. Hepatocyte plasma membrane glycospingolipid reactive with sera from patients with autoimmune chronic active hepatitis: Its identification as sulphatide
164. Sulphatide and sulphatide antibodies in insulin-dependent diabetes mellitis
165. Invited review: Immunopathogenesis and treatment of the Guillain-Barré syndrome, Part II
166. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts
167. Quantitative studies of F responses in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
168. Differentiation between axonal and demyelinating neuropathies: Identical segments recorded from proximal and distal muscles
169. Electrodiagnosis
170. How to recognize an antibody-mediated autoimmune disease: Criteria